Drug intelligence / Profile preview

Weikang Granules

Development stage: Unknown
Lead developer: Zhejiang Weikang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Weikang Granules (维康颗粒) is a traditional Chinese medicine formulation. The specific composition and mechanism of action for "Weikang Granules" are not detailed in the provided search results, and there is potential confusion with other products such as "Erdongtang Granules" (二冬汤颗粒), which are also developed by Zhejiang Weikang Pharmaceutical. However, based on available information, "Weikang Granules" refers to a proprietary Chinese herbal granule product produced by Zhejiang Weikang Pharmaceutical. Its primary indications, active ingredients, and mechanisms of action are not specified in the current sources.

Brand names: Weikang Granules
Other names: 维康颗粒

Targets

GLI1/2/3 (GLI family zinc finger proteins)NF-κBEGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on Weikang Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weikang Granules.

Explore the full profile